irreparable rotator cuff tears

临床试验

计划入组 20 人 · 首次发布于 2020 年 10 月 14 日

已完成

NCT04742452

Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

计划入组 41 人 · 首次发布于 2021 年 2 月 8 日

进行中（未招募）

NCT06258278

Clinical Results of Arthroscopic-Assisted Lower Trapezius Tendon Transfer for Massive, Irreparable Rotator Cuff Tears

计划入组 25 人 · 首次发布于 2024 年 2 月 14 日

药物

查看全部 23 →

Vitamin A Palmitate

Rx

Small Molecule

Approved

Boscalid

C₁₈H₁₂Cl₂N₂O

Small Molecule

Approved

Dextran(Bion Tears, Colirio Ocusan, Genteal Tears, Genteal Tears Mild, Tears Naturale, Tears Renewed)

相关疾病：Blood Circulation Disorder, Capillary disorder，另有 8 项

机构

查看全部 4 →

STAR SPORTS MED

DOUGLAS SEARS

United States

SMARTY EARS LLC

United States

资讯

查看全部 500 →

4个月前

FDA Grants Breakthrough Device Designation to SupraSpacer Implant for Irreparable Rotator Cuff Tears

去年

FDA Greenlights Phase 2 Trial of TPX-115 Cell Therapy for Rotator Cuff Tears

去年

临床试验

Superior Capsular Reconstruction Versus. Partial Repair for Irreparable Rotator Cuff Tears

Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

Clinical Results of Arthroscopic-Assisted Lower Trapezius Tendon Transfer for Massive, Irreparable Rotator Cuff Tears

药物

Vitamin A Palmitate

Boscalid

Dextran(Bion Tears, Colirio Ocusan, Genteal Tears, Genteal Tears Mild, Tears Naturale, Tears Renewed)

机构

STAR SPORTS MED

DOUGLAS SEARS

SMARTY EARS LLC

资讯

FDA Grants Breakthrough Device Designation to SupraSpacer Implant for Irreparable Rotator Cuff Tears

FDA Greenlights Phase 2 Trial of TPX-115 Cell Therapy for Rotator Cuff Tears

FDA Grants 510(k) Clearance to Atreon's BioCharge Matrix for Rotator Cuff Repair